Skip to Content
Merck
CN
  • Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.

Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.

Cancer cell (2018-12-07)
Christopher J Ott, Alexander J Federation, Logan S Schwartz, Siddha Kasar, Josephine L Klitgaard, Romina Lenci, Qiyuan Li, Matthew Lawlor, Stacey M Fernandes, Amanda Souza, Donald Polaski, Deepti Gadi, Matthew L Freedman, Jennifer R Brown, James E Bradner
ABSTRACT

Enhancer profiling is a powerful approach for discovering cis-regulatory elements that define the core transcriptional regulatory circuits of normal and malignant cells. Gene control through enhancer activity is often dominated by a subset of lineage-specific transcription factors. By integrating measures of chromatin accessibility and enrichment for H3K27 acetylation, we have generated regulatory landscapes of chronic lymphocytic leukemia (CLL) samples and representative cell lines. With super enhancer-based modeling of regulatory circuits and assessments of transcription factor dependencies, we discover that the essential super enhancer factor PAX5 dominates CLL regulatory nodes and is essential for CLL cell survival. Targeting enhancer signaling via BET bromodomain inhibition disrupts super enhancer-dependent gene expression with selective effects on CLL core regulatory circuitry, conferring potent anti-tumor activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-α-Tubulin antibody produced in mouse, ascites fluid, clone B-5-1-2
Supelco
1,25-Dihydroxyvitamin D3-13C3 (25,26,27-13C3) solution, 5 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®